DOSING OF A BRUTON'S TYROSINE KINASE INHIBITOR

DOSING OF A BRUTON'S TYROSINE KINASE INHIBITOR

The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1 -(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or apharmaceutically acceptable salt thereof for use in treating conditions such as cancer and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SMITH Steven August, KU Nora Chien Yee, BRANDHUBER Barbara Jean, NANDA Nisha, TSAI Donald
Format: Patent
Sprache:eng ; spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a method of administering doses of the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1 -(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide or apharmaceutically acceptable salt thereof for use in treating conditions such as cancer and autoimmune diseases. La presente invención proporciona un método para administrar dosis del inhibidor de BTK, (S)-5- amino-3-(4-((5-fluoro-2-metoxib enzamido)metil)fenil)-1-(1,1,1-trifluoropropan-2-il)-1H-pirazol-4 - carboxamida o una sal farmacéuticamente aceptable del mismo para su uso en el tratamiento de afecciones tales como cáncer y enfermedades autoinmunitarias.